Dr Concetta Bubici

Publications


Journals

  • Pham CG; Papa S; Bubici C; Zazzeroni F; Franzoso G. (1 Dec 2005). In the Crosshairs: NF-κB Targets the JNK Signaling Cascade. Curr Med Chem Anti Inflamm Anti Allergy Agents. 4:569-576. DOI.
  • Papa S; Bubici C; Zazzeroni F; Franzoso G. (Oct 2009). Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem. 390:965-976. DOI.
  • Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G. (2009). The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity. Methods Mol Biol. 512:169-207. DOI.
  • Papa S; Zazzeroni F; Fu YX; Bubici C; Alvarez K; Dean K; Christiansen PA; Anders RA; et alFranzoso G. (May 2008). Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest. 118:1911-1923. DOI.
  • Papa S; Monti SM; Vitale RM; Bubici C; Jayawardena S; Alvarez K; De Smaele E; Dathan N; et alPedone C; Ruvo M; Franzoso G. (29 Jun 2007). Insights into the structural basis of the GADD45beta-mediated inactivation of the JNK kinase, MKK7/JNKK2. J Biol Chem. 282:19029-19041. DOI.
  • Pham CG; Bubici C; Zazzeroni F; Knabb JR; Papa S; Kuntzen C; Franzoso G. (Jun 2007). Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol. 27:3920-3935. DOI.
  • Kuntzen C; Zazzeroni F; Pham CG; Papa S; Bubici C; Knabb JR; Franzoso G. (2007). A method for isolating prosurvival targets of NF-kappaB/Rel transcription factors. Methods Mol Biol. 399:99-124.
  • Papa S; Monti S; Vitale R; Bubici C; Jayawardena S; Alvarez K; De Smaele E; Dathan N; et alPedone C; Ruvo M; Franzoso G. (2007). Insights into the structural basis of the Gadd45ß mediated inactivation of the JNK kinase, MKK7. J Chem Biol. 282:19029-19041.
  • Bubici C; Papa S; Dean K; Franzoso G. (30 Oct 2006). Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 25:6731-6748. DOI.
  • Yang H; Bocchetta M; Kroczynska B; Elmishad AG; Chen Y; Liu Z; Bubici C; Mossman BT; et alPass HI; Testa JR; Franzoso G; Carbone M. (1 Oct 2006). TNF-alpha inhibits asbestos induced cytotoxicity via a NF-kappa B dependent pathway: A possible mechanism for asbestos-induced oncogenesis. LUNG CANCER. 54:S21-S21. Author weblink DOI.
  • Yang H; Bocchetta M; Kroczynska B; Elmishad AG; Chen Y; Liu Z; Bubici C; Mossman BT; et alPass HI; Testa JR; Franzoso G; Carbone M. (5 Jul 2006). TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A. 103:10397-10402. DOI.
  • Papa S; Bubici C; Zazzeroni F; Pham CG; Kuntzen C; Knabb JR; Dean K; Franzoso G. (May 2006). The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13:712-729. DOI.
  • Bubici C; Papa S; Pham CG; Zazzeroni F; Franzoso G. (Jan 2006). The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol. 21:69-80.
  • Papa S; Bubici C; Pham CG; Zazzeroni F; Franzoso G. (Oct 2005). NF-kappaB meets ROS: an 'iron-ic' encounter. Cell Death Differ. 12:1259-1262. DOI.
  • Pham CG; Papa S; Bubici C; Zazzeroni F; Franzoso G. (Apr 2005). Oxygen JNKies: phosphatases overdose on ROS. Dev Cell. 8:452-454. DOI.
  • Bubici C; Papa S; Pham CG; Zazzeroni F; Franzoso G. (Dec 2004). NF-kappaB and JNK: an intricate affair. Cell Cycle. 3:1524-1529.
  • Pham CG; Bubici C; Zazzeroni F; Papa S; Jones J; Alvarez K; Jayawardena S; De Smaele E; et alCong R; Beaumont C; Torti FM; Torti SV; Franzoso G. (12 Nov 2004). Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 119:529-542. DOI.
  • Papa S; Zazzeroni F; Pham CG; Bubici C; Franzoso G. (15 Oct 2004). Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci. 117:5197-5208. DOI.
  • Barnhart BC; Legembre P; Pietras E; Bubici C; Franzoso G; Peter ME. (4 Aug 2004). CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 23:3175-3185. DOI.
  • Papa S; Zazzeroni F; Bubici C; Jayawardena S; Alvarez K; Matsuda S; Nguyen DU; Pham CG; et alNelsbach AH; Melis T; De Smaele E; Tang WJ; D'Adamio L; Franzoso G. (Feb 2004). Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol. 6:146-153. DOI.
  • Zazzeroni F; Papa S; Algeciras-Schimnich A; Alvarez K; Melis T; Bubici C; Majewski N; Hay N; et alDe Smaele E; Peter ME; Franzoso G. (1 Nov 2003). Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood. 102:3270-3279. DOI.

Conferences

  • Papa S; Bubici C; Zazzeroni F; Franzoso G. Mechanisms of liver disease: cross-talk between the NF-kappa B and JNK pathways. 4th International Conference of the Collaborative Research Center 575 Experimental Hepatology (SFB 575), 7 Nov 2008 - 8 Nov 2008. 390:965-976. WALTER DE GRUYTER & CO (1 Oct 2009). Author weblink DOI.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook